Regular Article
Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization

https://doi.org/10.1053/jhin.2002.1373Get rights and content

Abstract

An outbreak of extended spectrum β-lactamase-producing Klebsiella pneumoniae (ESBLKp) infections in a neonatal intensive care unit (NICU) prompted a prospective investigation of colonization and infection with this pathogen. From August 1, 1997 to May 30, 1999, neonates admitted to the NICU for more than 24 h were screened for ESBLKp acquisition. Neonatal gastrointestinal screening was performed by means of faecal sampling within 48 h of admission and then weekly until discharge. Isolates were typed using pulsed-field gel electrophoresis (PFGE). Time-dependent proportional hazard models were used to identify independent effects of invasive procedures and antimicrobials after controlling for duration of stay at the NICU. During the study period, 464 neonates were admitted and 383 were regularly screened. Infections occurred in 13 (3.4%) neonates and 206 (53.8%) became colonized. Independent risk factors for colonization during the first nine days in the NICU were the antimicrobial combination cephalosporin plus aminoglycoside [hazard rate (HR)=4.60; 95% CI: 1.48–14.31], and each NICU-day was associated with a 26% increase in the hazard rate for colonization (HR=1.26; 95% CI: 1.16–1.37). Previous colonization (HR=5.19; 95% CI: 1.58–17.08) and central vascular catheter use (HR=13.89; 95% CI: 2.71–71.3) were independent risk factors for infection. In an outbreak setting the proportion of neonates colonized with ESBLKp was observed to increase with the duration of stay and antimicrobial use, and once colonized, infants exposed to invasive devices may become infected.

References (27)

  • K Tullus et al.

    Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime

    Antimicrob Agents Chemother

    (1990)
  • H Knothe et al.

    Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

    Infection

    (1983)
  • AC Gales et al.

    Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL) isolated in hospitals in Brazil

    Braz J Infect Dis

    (1997)
  • Cited by (0)

    Presented in part at the Fourth Decennial International Confer-ence on Nosocomial and Healthcare-Associated Infections, Atlanta, March 2000 (Infect Control Hosp Epidemiol 2002; 21: 127).

    f2

    Author for correspondence: Carmem Lúcia Pessoa da Silva, M.D. Unité de Prévention et Controle de l'Infection—UPCI, University Hospitals of Geneva, 24 rue Micheli du Crest—CH-1211 Geneva 14, Switzerland. Tel.: 41 22 3723854; Fax: 41 22 3723987; E-mail: [email protected]

    View full text